PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 211 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $4,723,000 | -26.8% | 241,964 | -0.1% | 0.54% | -16.5% |
Q3 2018 | $6,453,000 | -51.5% | 242,302 | -31.2% | 0.65% | -52.5% |
Q2 2018 | $13,306,000 | +50.8% | 352,302 | +30.4% | 1.36% | +25.2% |
Q1 2018 | $8,826,000 | -14.1% | 270,248 | +28.0% | 1.09% | -21.7% |
Q4 2017 | $10,279,000 | -36.0% | 211,153 | -29.0% | 1.39% | -32.3% |
Q3 2017 | $16,069,000 | +158.2% | 297,400 | +168.4% | 2.05% | +129.4% |
Q2 2017 | $6,224,000 | +31.5% | 110,805 | -8.3% | 0.89% | +19.2% |
Q1 2017 | $4,734,000 | +74.6% | 120,805 | 0.0% | 0.75% | +44.2% |
Q4 2016 | $2,711,000 | -99.9% | 120,805 | 0.0% | 0.52% | +19.3% |
Q3 2016 | $2,743,482,000 | +110613.6% | 120,805 | +15.1% | 0.44% | -0.9% |
Q2 2016 | $2,478,000 | +15.7% | 105,000 | 0.0% | 0.44% | +3.5% |
Q1 2016 | $2,142,000 | -32.9% | 105,000 | +69.4% | 0.42% | -11.8% |
Q4 2015 | $3,190,000 | +5.4% | 62,000 | -12.7% | 0.48% | 0.0% |
Q3 2015 | $3,026,000 | -12.6% | 71,000 | -6.6% | 0.48% | +15.9% |
Q2 2015 | $3,462,000 | – | 76,000 | – | 0.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |